Skip to main content
. 2022 Oct 11;11:106. doi: 10.1186/s40249-022-01032-5

Fig. 2.

Fig. 2

Exploration of strategies to achieve less than 0.1% prevalence among children under five by 2030. Estimation of the potential of expanding the coverage rate of antiviral treatment among childbearing-age patients with chronic HBV infection (including in PMTCT strategies) on achieving the 2030 Goals. HBV Hepatitis B virus, PMTCT Prevention of mother to child transmission